Explore
Validate
Learn
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA020522 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA020522, RRID:AB_2670463
- Product name
- Anti-AIF1L
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human AIF1L, Gene description: allograft inflammatory factor 1-like, Alternative Gene Names: C9orf58, FLJ12783, IBA2, Validated applications: IHC, Uniprot ID: Q9BQI0, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.4 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Allograft inflammatory factor-1-like is a situational regulator of leptin levels, hyperphagia, and obesity.
Allograft inflammatory factor-1-like is not essential for age dependent weight gain or HFD-induced obesity and glucose insensitivity.
Absence of AIF1L contributes to cell migration and a poor prognosis of breast cancer
Parikh D, Jayakumar S, Oliveira-Paula GH, Almonte V, Riascos-Bernal DF, Sibinga NES
iScience 2022 Oct 21;25(10):105058
iScience 2022 Oct 21;25(10):105058
Allograft inflammatory factor-1-like is not essential for age dependent weight gain or HFD-induced obesity and glucose insensitivity.
Parikh D, Riascos-Bernal DF, Egaña-Gorroño L, Jayakumar S, Almonte V, Chinnasamy P, Sibinga NES
Scientific reports 2020 Feb 27;10(1):3594
Scientific reports 2020 Feb 27;10(1):3594
Absence of AIF1L contributes to cell migration and a poor prognosis of breast cancer
Liu P, Li W, Hu Y, Jiang Y
OncoTargets and Therapy 2018;Volume 11
OncoTargets and Therapy 2018;Volume 11
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human kidney and skeletal muscle tissues using HPA020522 antibody. Corresponding AIF1L RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
